Literature DB >> 30222389

Advances in the Evaluation of Longitudinal Construct Validity of Clinical Outcome Assessments.

Valerie Williams1, Lori McLeod1, Lauren Nelson1.   

Abstract

Historically, the assessment of longitudinal construct validity in the field of psychosocial measurement involved defining hypotheses and calculating correlation coefficients using scores based on 2 measures at 2 or more time points. In the context of patient-reported outcomes, this evolved into sensitivity to change and responsiveness, including the computation of effect size estimates of change, standardized response means, and indices such as Guyatt's statistic. Cross-sectional analyses or analyses based on 2 time points have been the standard practice. Evolving conceptualizations have incorporated more than 2 time points and have included depictions of individual trajectories of change in multiple measures, structural equation models, and mixed modeling techniques. The focus of this article is on methods to evaluate longitudinal construct validity. We describe a sample of these methods and provide considerations and recommendations for designing a thoughtful longitudinal construct validity evaluation of clinical outcome assessments.

Entities:  

Keywords:  clinical outcome assessment; longitudinal construct validity; psychometrics; responsiveness; validation

Year:  2015        PMID: 30222389     DOI: 10.1177/2168479015609103

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN: 2168-4790            Impact factor:   1.778


  2 in total

1.  Psychometric evaluation of the Nocturia Sleep Quality Scale based on data from a prospective observational study.

Authors:  Valerie Williams; Shanshan Qin; Carla DeMuro Romano; Sandy Lewis; Nicole Williams; Stuart Yarr; Kristian V Juul; Fredrik L Andersson
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

2.  Development and psychometric validation of the Nausea/Vomiting Symptom Assessment patient-reported outcome (PRO) instrument for adults with secondary hyperparathyroidism.

Authors:  Colleen A McHorney; Mark E Bensink; Laurie B Burke; Vasily Belozeroff; Chad Gwaltney
Journal:  J Patient Rep Outcomes       Date:  2018-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.